Mylan New Zealand is one of the largest pharmaceutical companies in New Zealand. We specialise in off-patent medicines and focus on patient welfare to ensure our generic lines are both economical and of the highest quality.
Mylan’s long history in New Zealand began with Pacific Pharmaceuticals in 1977. The acquisition of Merck Generic in 2007 resulted in Pacific Pharmaceuticals transforming into Mylan New Zealand and joining forces with one of the world’s leading generics and specialty pharmaceutical companies, with sales in approximately 165 countries and territories.
We continue to submit one of the highest number of new medicine applications in the country, ready to seamlessly offer solutions to New Zealand’s changing health care demands. Mylan New Zealand maintains a broad product portfolio including prescription, non-prescription, and over the counter medicines.With its New Zealand office based in Auckland, Mylan New Zealand has expertise in quality, regulatory affairs, sales, marketing and customer service. Mylan’s representative teams service both pharmacy and general practice delivering personal support to New Zealand healthcare professionals across the country.